Our landmark ELSA study (Early Surveillance for Autoimmune diabetes) has shown that childhood screening for type 1 diabetes works.

A diabetes diagnosis can be life-changing. We explore the impact of finding out you have diabetes - from the initial shock to dealing with your emotions and everything in between. Diabetes doesn't ...

There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...

Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

Missed checks, disrupted care and health inequalities have been revealed in our new report looking at the state of diabetes care in England.

A Parliamentary Inquiry report has highlighted the risks of disordered eating among people living with type 1 diabetes and calls for essential changes to be made to provide effective care.

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...

Suicide and diabetes isn't something that's generally talked about. But we should be talking about it, says Simon O'Neill, our Director of Health Intelligence and Professional Liaison. Here he ...